Five states join the FTC's privacy and billing lawsuit against Hims & Hers
Five states joined the FTC's lawsuit against Hims & Hers, alleging privacy violations and deceptive billing practices. The FTC claims Hims shared health data with third parties and hid cancellation terms. Hims plans to defend itself, calling the new claims 'follow-on' allegations. The company recently reported a 49% revenue increase to $890 million but cut its 2026 profit outlook.
How this was made
The 30-second read
Why it matters
The lawsuit could lead to fines, mandated changes to billing practices, and heightened compliance costs.
Market read
First disclosure of the expanded FTC suit adds material legal risk for HIMS, likely prompting short‑term price decline.
What to watch
Potential impact of recent board addition (Andrew Huberman) on public perception and future compliance initiatives.
Background
The FTC originally sued Hims & Hers in July; the amendment adds five states, increasing the breadth of consumer protection claims.
Ticker impact
FTC lawsuit expanded with five states joining as co-plaintiffs, adding new consumer protection claims against Hims & Hers.
likely downward pressure as investors price in legal costs and possible fines
First report of the lawsuit amendment; legal exposure is material for a mid‑cap telehealth firm.
Market effects
Telehealth and digital health companies may face increased regulatory scrutiny.
U.S. market participants may reassess exposure to health‑tech stocks.
Limited to U.S. listed health‑tech firms.
Counterpoint
If the FTC's case stalls, the stock could rebound on short‑term overreaction.
Key entities
- companyHims & Hers Health, Inc.
Telehealth provider facing FTC enforcement action.
- regulatorFederal Trade Commission
U.S. agency filing the amended complaint.
